Engaging with social entrepreneurs for sustainable health solutions

  • More Potential
  • More Health

Engaging with social entrepreneurs for sustainable health solutions

Making More Health (MMH) is one of our flagship initiatives aimed at creating healthy, inclusive, and sustainable communities around the world. We spoke to Dr. Ilka Wicke, Head of Sustainability Social, about how it has evolved and where it is headed.

Dr. Ilka Wicke, Head of Sustainability Social at Boehringer Ingelheim

Dr. Wicke, would you give us a quick overview of the MMH initiative?

MMH began in 2010 as a partnership with the social entrepreneur network Ashoka. Since then, it has evolved into a many-faceted program, which is continuously forging new partnerships and developing innovative models to amplify social impact. Its goal is to improve health in underserved communities by identifying and supporting the most promising solutions to challenging health issues.

Can you expand on some of those issues?

When you look around the world, one of the most pressing issues in healthcare is achieving greater health equity. In underserved communities in particular, enabling better access to healthcare and optimal health outcomes remains an ongoing challenge. That is why equitable health is a cornerstone of our commitment with the work we do through MMH – and aligned with Boehringer’s 2030 sustainability commitments. For example, at our annual Making More Health Together convention, last year we invited MMH fellow Katie Plohocky to speak and share her insights on challenges of “food deserts” in the USA and the solutions she is creating to bring fresh food back to disadvantaged communities.

What do food deserts have to do with health?

This is important: We understand that many health issues can be created or exacerbated due to the food we eat. Looking at the bigger picture, through MMH’s long track record of social engagement, we have seen firsthand how interconnected health is with many other issues. Infrastructure, economic development, education, culture – all these fields interact with and impact one other.

That’s where our “Social Engagement Continuum” (see below) comes in. Its goal is to use many different approaches to address diverse needs in communities, while linking these interdependent issues with one another. It extends from supporting underserved communities through community activation, engaging with social entrepreneurs on their promising and innovative models as well as support social startups through grants and impact investments, to developing and sustaining social impact. This holistic approach is demonstrating great potential for creating better – and more sustainable – solutions and is now a vital part of our sustainability framework.

Can you explain how MMH and sustainability intersect?

MMH aligns closely with many of the United Nations’ Sustainable Development Goals (SDGs). This is particularly evident in SDG 3 (health), which is at the core of our mission. Additionally, MMH’s work also aligns with SDG2 (zero hunger), SDG 8 (decent work and economic growth), SDG 11 (sustainable cities and communities) and SDG 17 (partnerships). And I can share that, in many ways, we were ahead of the curve with MMH. The SDGs were born at the UN Conference on Sustainable Development in Rio de Janeiro in 2012 – by that time, MMH was already two years old.

What milestones stand out to you since MMH’s inception?

I am pleased to share that we have implemented a continuous social business strategy to support social start-ups along their journey. We have engaged with more than 130 social entrepreneurs to date in collaboration with partners like Villgro Africa and Ashoka. Since 2018, we were able to support over 30 social businesses in Sub-Saharan Africa, helping them develop their business ideas to address high unmet needs such as maternal health or chronic kidney diseases. Recognizing that innovative young entrepreneurs were facing critical barriers in the early stages, MMH also set up the Rising Stars incubator for healthcare start-ups. This was complemented by the Boehringer Ingelheim Social Engagement (BISE) fund in 2021. This 50 million EUR fund uses financing tools linked to in-kind contributions from our employees and partners to scale and sustain social startups. One of its first recipients was Geneplus, an agricultural biotech company from Kenya that helps small-scale farmers increase their productivity and profitability.

And what does the future hold for MMH?

Our overarching goal remains the same: to offer diverse, yet complementary opportunities to help overcome barriers and enable better healthcare solutions. We are entering the next phase of our journey, and in future partnerships will become even more essential to help us achieve our commitments. For example, last year we made the strategic decision to partner with Villgro Africa, an impact investor incubator that supports early-stage social entrepreneurs in Africa. Social innovation is a powerful catalyst for sustainable health solutions. We are convinced that by collaborating with strong partners on an equal footing, we can jointly make an even bigger difference in peoples’ lives.

Achieving a holistic approach through our Social Engagement Continuum:

Non-Profit

Donations

Community Activation

Donations

Social Enterpreneurs

Social Business

Grants

Social Business Incubator

Grants

Social Business Accelerator

Social Business

Investments

Social Engagement Fund

161
social entrepreneurs supported since 2010
Over
30
social start-ups since 2018
Invested in
5
start-ups since 2022

Non-Profit - Donations

Community Activation

Boehringer Ingelheim supports underserved communities while networking and co-creating with NGOs, social enterprises, and other stakeholders.

“Health is closely linked to environment, infrastructure, education, beliefs, and taboos, as well as financial set-ups and societal factors. More health is not possible if all basic needs are not tackled equally.“

Manuela Pastore, Associate Director Community Activation, Boehringer Ingelheim

Non-Profit - Donations

Social Enterpreneurs

A long-term partnership between Ashoka and Boehringer Ingelheim that is designed to bring innovative ideas in social entrepreneurship in the fields of human and animal health to life.

“Our vast and powerful network of 140 Making More Health Fellows around the world is a true driver of change for underserved communities.”

Hilke Rosskamp, Senior Manager Sustainability Social, Boehringer Ingelheim

Social Business - Grants

Social Business Incubator

The comprehensive Rising Stars incubator program helps early-stage social start-ups to develop their business models for more impact. The incubator therefore delivers grant support, technical expertise, as well as access to knowledge and a strategic network.

“The incubator is unlocking unique growth opportunities for early start-ups. Grants, as well as expert support, are key to preparing for the acceleration phase ahead of engaging third party investors.”

Christopher Imbaya, Senior Manager Making More Health, Sub-Saharan Africa

Social Business - Grants

Social Business Accelerator

In a structured 11-month business accelerator program, cohorts of experienced social entrepreneurs in the healthcare space are identified and provided with capacity building as well as technical and financial support. The Making More Health Business Accelerator aims to develop, pilot, test, and present their innovations to investors.

“The Making More Health business accelerator has supported Bena Care in our mission to lower healthcare costs for low-income families. We have been able to serve more than 7,000 patients in the comfort of their own homes and saved them more than USD 50 million in health-care costs.”

Naom Monari, Founder Bena Care

Social Business - Investments

Social Engagement Fund

Boehringer Ingelheim Social Engagement closes critical financing gaps for earlystage social entrepreneurs to support them in scaling-up their business. This is done through impact investment and post-transaction, non-financial support. The funding supports social start-ups that are providing human and animal health solutions in underserved communities to enable systemic change. With 50 million euros at its disposal, Boehringer Ingelheim Social Engagement is designed to offer non-traditional, impact-first-focused financing options, combined with bringing in like-minded partners.

“We believe that all farmers must have access to vaccines and animal medication. This is the reason we leverage tech-nology to bridge the critical last mile to make this possible. By forming strategic partner- ships with organizations such as Boehringer Ingelheim, we make sure that no farmer is left behind.”

Peter Awin, CEO of Cowtribe, Ghana

Feature: Geneplus aims to increase productivity of rural farmers in Kenya

In Kenya, limited access to animal health solutions and efficient farming measurements can lead to harmful consequences for small-scale farmers through reduced economic income and food security. Having experienced the struggles of small-hold Kenyan farmers firsthand, Dr. Chris Silali founded a healthcare technology company named Geneplus. His mission: To increase the productivity, profitability, and sustainability of farmers’ enterprises. The start-up’s innovative idea is to use easily accessible mobile technology to improve artificial insemination access for rural farmers, along with quality feed and vaccines. This has the potential to enhance the productivity of millions of cows, increasing milk production from 8 to 15 liters per day.

Offering a helping hand to mitigate initial risks

Supporting social innovators like Dr. Silali is a promising approach to drive sustainable health solutions in underserved communities. However, too few of these trailblazers can move forward with their ideas, since they often struggle to find funding. A hurdle Dr. Silali faced, too. “Initial capital came from my savings and selling some property,” he recounts. Turns out that establishing and running an end-to-end cold chain network across East Africa - which includes liquid nitrogen tanks and transport vehicles - is a massive investment. “In the beginning we didn’t even have our own vehicles,” Dr. Silali says. “We were using vehicle rental services to make sure our teams were in the markets.” What ultimately made Dr. Silali’s social entrepreneurial journey a little less intimidating was the support of Boehringer and MMH.

Geneplus enables farmers to increase their milk production from
8 to 15
liters per day.

Incubator Rising Stars unlocks future potential

In 2022 Dr. Silali applied and was accepted into MMH’s “Rising Stars” program, which is designed to address the critical funding barriers and capacity-building resources that often hinder young healthcare start-ups in Sub-Saharan Africa from realizing their innovative ideas. Geneplus received a $20,000 grant which proved instrumental in helping the start-up expand its cold-chain infrastructure, further develop its business, and ultimately reach almost 30,000 more farmers than before. “I am very passionate about bringing change to underserved communities, and this was a huge opportunity for Geneplus,” Dr. Silali explains. “It opened us up to the world.”

Geneplus bridges technological gaps and has managed to reach even the moste remote farmers.

A continuum of support for social enterprises

Since then, the young company has been on a roll. It is participating in the MMH Business Accelerator cohort, a program where social entrepreneurs can develop, pilot, test, and present their innovations to investors. During the MMH Together convention in October 2023, Geneplus – together with Ilara Health – was announced as the next Boehringer Ingelheim Social Engagement’s (BI SE) impact investment recipient. BI SE provides financing for impact to social businesses serving underserved communities worldwide through non-traditional financing options, combined with a partnering approach and the support of our employees. “We are proud to support social entrepreneurs like Dr. Silali along their entire business journey with these initiatives,” says Dennis Mbugua, MMH Manager in Sub-Saharan Africa.

“I am very passionate about bringing change to underserved communities, and this was a huge opportunity for Geneplus. It opened us up to the world.”

Dr. Chris Silali

Dr. Chris Silali, Founder of Geneplus and recipient of the BI SE program

On a path to sustainable success with technology and education

This confidence in Geneplus is well-founded, because the company has a solid portfolio in place and a clear strategy for the future. It is helping farmers access breeding services within 3-5 minutes using a code-based text messaging platform that works on even basic mobile phones. To further improve stock productivity, Geneplus is also planning an AI-powered platform designed to educate farmers on animal management. “Through Geneplus, I have a chance to bring something positive to smallholder farmers,” Dr. Silali concludes, “and I am delighted to partner with BI SE and further our cause to make animal health solutions accessible for these communities.”

Dr. Chris Silali (Geneplus) and Emilian Popa (Ilara Health) with Boehringer Ingelheim representatives during the Making More Health Together 2023 convention.